Page 401 - Read Online

Paap et al. Plast Aesthet Res 2020;7:36 I http://dx.doi.org/10.20517/2347-9264.2020.121 Page 11 of 11

15. Flynn TC, Thompson DH, Hyun SH. Molecular weight, analyses and enzymatic degradation profiles of the soft-tissue fillers Belotero
Balance, Restylane, and Juvederm Ultra. Plast Reconstr Surg 2013;132:22S-32.
16. Shumate GT, Chopra R, Jones D, Messina DJ, Hee CK. In vivo degradation of crosslinked hyaluronic acid fillers by exogenous
hyaluronidases. Dermatol Surg 2018;44:1075-83.
17. Buhren BA, Schrumpf H, Bolke E, Kammers K, Gerber PA. Standardized in vitro analysis of the degradability of hyaluronic acid fillers
by hyaluronidase. Eur J Med Res 2018;23:37.
18. Juhasz MLW, Levin MK, Marmur ES. The kinetics of reversible hyaluronic acid filler injection treated with hyaluronidase. Dermatol
Surg 2017;43:841-7.
19. Dunn AL, Heavner JE, Racz G, Day M. Hyaluronidase: a review of approved formulations, indications and off-label use in chronic pain
management. Expert Opin Biol Ther 2010;10:127-31.
20. Weber GC, Buhren BA, Schrumpf H, Wohlrab J, Gerber PA. Clinical applications of hyaluronidase. In: Labrou N, editor. Therapeutic
enzymes: function and clinical implications. New York: Springer; 2019. pp. 255-78.
21. Food and Drug Administration. Dermal Fillers Approved by the Center for Devices and Radiological Health. Available from: https://
www.fda.gov/medical-devices/cosmetic-devices/dermal-fillers-approved-center-devices-and-radiological-health [Last accessed on 6 Jul
2020]
22. Gold MH. What’s new in fillers in 2010? J Clin Aesthet Dermatol 2010;3:36-45.
23. Agerup B, Berg P, Akermark C. Non-animal stabilized hyaluronic acid: a new formulation for the treatment of osteoarthritis. BioDrugs
2005;19:23-30.
24. Mansouri Y, Goldenberg G. Update on hyaluronic acid fillers for facial rejuvenation. Cutis 2015;96:85-8.
25. Philipp-Dormston WG, Wong C, Schuster B, Larsson MK, Podda M. Evaluating perceived naturalness of facial expression after fillers to
the nasolabial folds and lower face with standardized video and photography. Dermatol Surg 2018;44:826-32.
26. U.S. National Library of Medicine. Study to Evaluate Satisfaction After Treatment with Kysse. Available from: https://clinicaltrials.gov/
ct2/show/NCT03967444 [Last accessed on 24 Apr 2020]
27. Allemann IB, Baumann L. Hyaluronic acid gel (Juvéderm) preparations in the treatment of facial wrinkles and folds. Clin Interv Aging
2008;3:629-34.
28. Monheit G, Beer K, Hardas B, Grimes PE, Weichman BM, et al. Safety and effectiveness of the hyaluronic acid dermal filler VYC-17.5L
for nasolabial folds: results of a randomized, controlled study. Dermatol Surg 2018;44:670-8.
29. Devgan L. Abstract: Juvéderm Volbella for use in periorbital volumization. Plast Reconstr Surg Glob Open 2017;5:192-3.
30. Niforos F, Ogilvie P, Cavallini M, Leys C, Chantrey J, et al. VYC-12 injectable gel is safe and effective for improvement of facial skin
topography: a prospective study. Clin Cosmet Investig Dermatol 2019;12:791-8.
31. Prasetyo AD, Prager W, Rubin MG, Moretti EA, Nikolis A. Hyaluronic acid fillers with cohesive polydensfied matrix for soft-tissue
augmentation and rejuvenation: a literature review. Clin Cosmet Investig Dermatol 2016;9:257-80.
32. Palm MD. Filler frontier: what’s new and heading West to the US market. Semin Cutan Med Surg 2014;33:157-63.
33. Lee A, Grummer SE, Kriegel D, Marmur E. Hyaluronidase. Dermatol Surg 2010;36:1071-7.
34. Landau M. Hyaluronidase caveats in treating filler complications. Dermatol Surg 2015;41:S347-53.
35. Delorenzi C. Complications of injectible fillers, part I. Aesthet Surg J 2013;33:561-75.
36. Vartanian AJ, Frankel AS, Rubin MG. Injected hyaluronidase reduces Restylane-mediated cutaneous augmentation. Arch Facial Plast
Surg 2005;7:231-7.